Scisparc announces initiation of randomized phase iib clinical trial of its proprietary sci-110 for tourette syndrome

Initiation of trial to take place at the tel aviv sourasky medical center, the israeli clinical trial site tel aviv, israel, sept. 07, 2023 (globe newswire) -- scisparc ltd.

SPRC Ratings Summary

SPRC Quant Ranking